These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24236797)

  • 1. Comparative effectiveness research in localized prostate cancer treatment.
    Hoffman RM; Penson DF; Zietman AL; Barry MJ
    J Comp Eff Res; 2013 Nov; 2(6):583-93. PubMed ID: 24236797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.
    Shen X; Zaorsky NG; Mishra MV; Foley KA; Hyslop T; Hegarty S; Pizzi LT; Dicker AP; Showalter TN
    Future Oncol; 2012 Jan; 8(1):37-54. PubMed ID: 22149034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data.
    Serrell EC; Pitts D; Hayn M; Beaule L; Hansen MH; Sammon JD
    Urol Oncol; 2018 Apr; 36(4):183-192. PubMed ID: 29122446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing outcomes in genitourinary cancers across the treatment continuum.
    Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
    BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for localized prostate cancer.
    Mohan R; Schellhammer PF
    Am Fam Physician; 2011 Aug; 84(4):413-20. PubMed ID: 21842788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of localized prostatic cancer--different alternatives. Patients with localized prostatic cancer must actively participate in the choice of therapy].
    Adolfsson J
    Lakartidningen; 2000 Sep; 97(36):3870-4. PubMed ID: 11036336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
    Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
    BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.
    Vickers AJ
    J Natl Cancer Inst; 2011 Jul; 103(14):1134; author reply 1134-5. PubMed ID: 21690487
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient-centered comparative effectiveness research: essential for high-quality care.
    Slutsky JR; Clancy CM
    Arch Intern Med; 2010 Mar; 170(5):403-4. PubMed ID: 20212173
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant).
    Jayadevappa R; Chhatre S; Wong YN; Wittink MN; Cook R; Morales KH; Vapiwala N; Newman DK; Guzzo T; Wein AJ; Malkowicz SB; Lee DI; Schwartz JS; Gallo JJ
    Medicine (Baltimore); 2017 May; 96(18):e6790. PubMed ID: 28471976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer.
    Bradley LA; Palomaki GE; Gutman S; Samson D; Aronson N
    J Urol; 2013 Aug; 190(2):389-98. PubMed ID: 23545099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, management and screening of early localised prostate cancer.
    Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
    Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.